{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:21:23Z","timestamp":1791822083806,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10157-011-0437-x","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T03:16:57Z","timestamp":1300936617000},"page":"586-590","source":"Crossref","is-referenced-by-count":12,"title":["Renal failure caused by plasma cell infiltration in multiple myeloma"],"prefix":"10.1007","volume":"15","author":[{"given":"Shiho","family":"Hanawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kotoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masuzu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wako","family":"Yumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiya","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,1]]},"reference":[{"key":"437_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00005792-198009000-00005","volume":"59","author":"SB Kapadia","year":"1980","unstructured":"Kapadia SB. Multiple myeloma: a clinicopathological study of 62 consecutively autopsied cases with multiple myeloma. Medicine. 1980;59:380\u201392.","journal-title":"Medicine"},{"key":"437_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajh.1067","volume":"67","author":"K Oshima","year":"2001","unstructured":"Oshima K, Kanda Y, Nannya Y, Kaneko M, Hamaki T, Suguro M, et al. Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma. Am J Hematol. 2001;67:1\u20135.","journal-title":"Am J Hematol"},{"key":"437_CR3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.5858\/2004-128-875-RPSIAA","volume":"128","author":"GA Herrera","year":"2004","unstructured":"Herrera GA, Joseph L, Gu X, Hough A, Barlogie B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004;128:875\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"437_CR4","unstructured":"The kidney in multiple myeloma. West J Med. 1978;129:41\u20138."},{"key":"437_CR5","first-page":"222","volume":"27","author":"S Pasquali","year":"1987","unstructured":"Pasquali S, Zucchelli P, Casanova S, Cagnoli L, Confalonieri R, Pozzi C, et al. Renal histological lesions and clinical syndromes in multiple myeloma. Clin Nephrol. 1987;27:222\u20138.","journal-title":"Clin Nephrol"},{"key":"437_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.anndiagpath.2005.09.015","volume":"10","author":"SE Lommatzsch","year":"2006","unstructured":"Lommatzsch SE, Bellizzi AM, Cathro HP, Rosner MH. Acute renal failure caused by renal infiltration by hematolymphoid malignancy. Ann Diag Pathol. 2006;10:230\u20134.","journal-title":"Ann Diag Pathol"},{"key":"437_CR7","unstructured":"Herrera GA, Picken MM. Renal diseases associated with plasma cell dyscrasias, amyloidosis, Waldenstr\u00f6m macroglobulinemia, and cryoglobulinemic nephropathies. In: Jennette JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall\u2019s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 853\u2013910."},{"key":"437_CR8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJM198312223092503","volume":"309","author":"JM Ginsberg","year":"1983","unstructured":"Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543\u20136.","journal-title":"N Engl J Med"},{"key":"437_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.seminhematol.2009.02.004","volume":"46","author":"MC Kyrtsonis","year":"2009","unstructured":"Kyrtsonis MC, Maltezas D, Tzenou T, Koulieris E, Bradwell AR. Staging system and prognostic factors as a guide to therapeutic decisions in multiple myeloma. Semin Hematol. 2009;46:110\u20137.","journal-title":"Semin Hematol"},{"key":"437_CR10","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1681\/ASN.2006020139","volume":"17","author":"SM Korbet","year":"2006","unstructured":"Korbet SM, Schwartz MM. Multiple myeloma. J Am Soc Nephrol. 2006;17:2533\u201345.","journal-title":"J Am Soc Nephrol"},{"key":"437_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/ki.2008.138","volume":"74","author":"L Pillon","year":"2008","unstructured":"Pillon L, Sweeting RS, Arora A, Notkin A, Ballard HS, Wieczorek RL, et al. Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there still a role for plasmapheresis? Kidney Int. 2008;74:956\u201361.","journal-title":"Kidney Int"},{"key":"437_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7326\/0003-4819-93-1-43","volume":"93","author":"WA Border","year":"1980","unstructured":"Border WA, Cohen AH. Renal biopsy diagnosis of clinically silent multiple myeloma. Ann Int Med. 1980;93:43\u20136.","journal-title":"Ann Int Med"},{"key":"437_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0272-6386(83)80075-4","volume":"2","author":"GS Hill","year":"1983","unstructured":"Hill GS, Morel-Maroger L, M\u00e9ry JP, Brouet JC, Mignon F. Renal lesions in multiple myeloma: their relationship to associated protein abnormalities. Am J Kidney Dis. 1983;2:423\u201338.","journal-title":"Am J Kidney Dis"},{"key":"437_CR14","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/ndt\/13.6.1438","volume":"13","author":"JJ Montseny","year":"1998","unstructured":"Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant. 1998;13:1438\u201345.","journal-title":"Nephrol Dial Transplant"},{"key":"437_CR15","unstructured":"Laszik ZG, Silva FG. Hemolytic uremic syndrome, thrombotic thrombocytopenic perpura, and other thrombotic microangiopathies. In: Jennette JC, Olson JL, Schwartz MM, Silvia FG, editors. Heptinstall\u2019s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 701\u201364."},{"key":"437_CR16","first-page":"571","volume":"27","author":"Z Galani","year":"2007","unstructured":"Galani Z, Viniou N, Kyrtsonis MC, Sachanas S, Antoniou T, Dimopoulou MN, et al. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission. Anticancer Res. 2007;27:571\u20134.","journal-title":"Anticancer Res"},{"key":"437_CR17","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1053\/j.ajkd.2003.08.040","volume":"42","author":"C Pozzi","year":"2003","unstructured":"Pozzi C, D\u2019Amico M, Fogazzi GB, Curioni S, Ferrario F, Pasquali S, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis. 2003;42:1154\u201363.","journal-title":"Am J Kidney Dis"},{"key":"437_CR18","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/ndt\/gfh201","volume":"19","author":"L Sellin","year":"2004","unstructured":"Sellin L, Friedl C, Klein G, Waldherr R, Rump LC, Weiner SM. Acute renal failure due to a malignant lymphoma infiltration uncovered by renal biopsy. Nephrol Dial Transplant. 2004;19:2657\u201360.","journal-title":"Nephrol Dial Transplant"},{"key":"437_CR19","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/leu.2008.131","volume":"22","author":"MA Dimopoulos","year":"2008","unstructured":"Dimopoulos MA, Kastritis E, Rosinol L, Blade J, Ludwig H. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia. 2008;22:1485\u201393.","journal-title":"Leukemia"},{"key":"437_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","volume":"158","author":"J Blade","year":"1998","unstructured":"Blade J, Fernandez-Llama P, Bosch F, Montoliu J, Lens XM, Montoto S, et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998;158:1889\u201393.","journal-title":"Arch Intern Med"},{"key":"437_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3324\/haematol.10759","volume":"92","author":"E Kastritis","year":"2007","unstructured":"Kastritis E, Anagnostopoulos A, Roussou M, Gika D, Matsouka C, Barmprousi D, et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents. Haematologica. 2007;92:546\u20139.","journal-title":"Haematologica"},{"key":"437_CR22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.leukres.2010.04.024","volume":"34","author":"M Roussou","year":"2010","unstructured":"Roussou M, Kastritis E, Christoulas D, Migkou M, Gavriatopoulou M, Grapsa I, et al. Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents. Leuk Res. 2010;34:1395\u20137.","journal-title":"Leuk Res"},{"key":"437_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0609.2009.01385.x","volume":"84","author":"F Morabito","year":"2010","unstructured":"Morabito F, Gentile M, Ciolli S, Petrucci MT, Galimberti S, Mele G, et al. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian myeloma network GIMEMA. Eur J Haematol. 2010;84:223\u20138.","journal-title":"Eur J Haematol"},{"key":"437_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2215\/CJN.04590908","volume":"4","author":"CA Hutchison","year":"2009","unstructured":"Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, et al. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol. 2009;4:745\u201354.","journal-title":"Clin J Am Soc Nephrol"},{"key":"437_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1365-2141.1995.tb05400.x","volume":"91","author":"RTJ Blade","year":"1995","unstructured":"Blade RTJ, Lopez-Pedret ACJ, Rozman MC, Revert L. Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases. Br J Haematol. 1995;91:854\u20139.","journal-title":"Br J Haematol"},{"key":"437_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00432-004-0593-4","volume":"130","author":"E Terpos","year":"2004","unstructured":"Terpos E, Politou M, Rahemtulla A. Tumor lysis sundrome in multiple myeloma after bortezomib (VELCADE) administration. J Cancer Res Clin Oncol. 2004;130:623\u20135.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-011-0437-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0437-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T16:42:51Z","timestamp":1637426571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-011-0437-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s10157-011-0437-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}